Delivering Science Supporting Healthcare

Neurone Specific Enolase (NSE)

Test Background

NSE is a glycolytic enzyme enolase (2-phospho-D-glyceratehydrolase) normally present in neurones, peripheral nerve tissues and neuroendocrine tissues, especially in the cells of the Amine Precursor Uptake Decarboxylation (APUD) system. It is in the form of dimers αγ and γγ with a molecular weight of approximately 95 kDa. Elevated levels occur in tumours of neuroectodermic or neuroendocrine origin, namely small-cell carcinoma of the lungs (SCLC), neuroblastoma, medullary thyroid carcinoma, carcinoid tumours, pancreatic endocrine tumours, seminoma and melanoma.
Moderate elevations are also seen in some colorectal and breast cancers, and in patients with benign lung diseases.

Clinical Indications

Lung cancer

Diagnosis: although NSE does not have sufficient sensitivity or specificity for use in screening, several studies support its use as an aid in the diagnosis of SCLC. High serum levels of NSE (>100 μg/L) in patients with suspicion of malignancy suggest the presence of SCLC with high probability, with differential diagnoses including neuroendocrine tumours of other organs.

Prognosis and monitoring: the prognostic value of NSE has been demonstrated in both SCLC and non-small cell lung cancer (NSCLC). NSE has shown considerable potential for the monitoring of post-treatment SCLC as well as for the detection of recurrent disease after primary therapy.

Other uses

- Treatment and follow-up monitoring of neuroblastoma.
- Differential diagnosis between Wilm’s tumour and neuroblastoma in children.

Reference Range

≤16.3 µg/L

Sample volume
0.5 mL
Turnaround time
4 weeks
Sample & Container Required
SST (gold top) preferred, serum (red top) accepted
Transport Storage
Samples should be stored at -20ºC within 24 hours of separation. Send samples frozen.
Notes

Roche Cobas E411 method.

As NSE is present in erythrocytes, plasma cells and platelets, serum or plasma must be separated from red cells within 60 minutes of venepuncture to avoid spuriously high results.

Falsely low results may be obtained for this test due to biotin interference. Samples should not be taken from patients receiving therapy with high biotin doses (>5 mg/day) until at least 8 hours (ideally 2 days) following the last biotin administration.

Haemolysed samples are not suitable for analysis.

 

Record last updated
August 26, 2025

Sample Container

5ml SST Vacutainers (Gold / Yellow top)

Sample Container

6ml Plain Vacutainers (Red top)

Search test database

Test Results

Yes, we have a Pathology User Guide

Yes. Please email your request to Imperial.nwlpcustomerservice@nhs.net

Results are communicated to clinical staff and are normally not communicated direct to patients either on telephone requests or in written report. If you need to contact us please click here to view the contact details page

Please contact the Customer Service Team Monday to Friday from 8:30am – 6:00pm on 0203 313 5353. Alternatively, see the Pathology User Guide for how to contact the relevant department. If advice is not urgent you can also email your query to Imperial.nwlpcustomerservice@nhs.net

Additional tests may be added by discussion with the relevant laboratory. The time limit for adding additional tests to a sample already received in the laboratory will depend on the type of sample and the department it was sent to.

Information on the repertoire of tests performed by pathology, including reference ranges, turnaround times and specimen requirements, can be found in the test directory.

NWLP operates UKAS accredited medical laboratories as per the references below. The current scope of accreditation for all NWLP’s laboratories can be found on the UKAS website.

See the following UKAS ref numbers:

  • Clinical Biochemistry Ref: 8673
  • Haematology and Blood Transfusion Ref: 8674
  • Infection & Immunity Sciences (Including Immunology, Virology, Microbiology and Histocompatibility and Immunogenetics ) Ref: 8659
  • Cellular Pathology (Including Histopathology, Cytology and Molecular Pathology) Ref: 9615

If you require copies of our certificate of accreditation and associated documentation please contact Imperial.nwlpcustomerservice@nhs.net.

UKAS requires the laboratories to be accredited for a particular repertoire/scope (ISO15189), any changes or additions to repertoire require assessment by UKAS (extension to scope).

The BD Hospital Tube GuideBD GP Tube Guide and BD Paediatric Tube Guide provide visual references to the correct tube types and collection instructions.

Home testing

INSTRUCTION SHEET FOR BLOOD SAMPLE COLLECTION 

We also have two instruction videos available (one with subtitles and one without) – please click on the links to view the videos on Google.

VIDEO ON BLOOD SAMPLE COLLECTION (without subtitles)

VIDEO ON BLOOD SAMPLE COLLECTION (with subtitles)

Our accreditations

Upholding excellence in diagnostic standards

Our laboratories are accredited by the UK Accreditation Service (UKAS) against the international standard ISO15189:2022. UKAS is the accreditation body for the UK that assesses medical laboratories.

Find out more about our accreditations on the UKAS website.

UKAS website
Man in the lab handling a sample